Hjem › Geografisk atrofi › Georgia
Geografisk atrofi kliniske forsøg i Georgia
4 studier for Geografisk atrofi søger deltagere på steder i Georgia.
Officiel studietekst (engelsk)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Georgia Retina, Marietta
- Marietta Eye Clinic, Marietta
RekruttererFase 2/3
Alder 60 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06635148A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Southeast Retina Center- Site Number : 8400044, Augusta
RekruttererFase 1/2
Alder 60 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07215234A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Southeast Retina Center, Augusta
- Georgia Retina - Marietta, Marietta
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Emory University Eye Center, Atlanta
RekruttererFase 1
Alder 50 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT03178149Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.